CLOs on the Move

QurAlis

www.quralis.com

 
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.quralis.com
  • 100 Cambridgepark Drive 5th Floor
    Cambridge, MA USA 02140
  • Phone: 781.816.7031

Executives

Name Title Contact Details
Bryan Boggs
Vice President of Regulatory Affairs Profile

Similar Companies

Micronics

Micronics is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Scipher Medicine

Most patients who are prescribed blockbuster therapies today don`t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher`s platform identifies which drug will work based on the patient`s fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

Athenix

Athenix Corp. is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tri-Source Pharma

Tri-Source Pharma is a pharmaceutical manufacturer/distributor operating in both the human and animal health care industries.

Soliance

Soliance is a Allendale, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.